Drugs Made In America Acquisition Corp. Ordinary Shares

NASDAQ:DMAA

Shell Companies

Financial Services
$10.90 +0.00%

+$0.00 today

Market cap
$264.62M
Beta
0.00
P/E (TTM)
36.7
EPS (TTM)
$0.29
52W Low $10.17High $10.63

Volume 0.00M

Average 0.11M

DMAA Capital Expenditures

Cash spent on property, plant, equipment, and other long-term assets.

Drugs Made In America Acquisition Corp. Ordinary SharesNASDAQ: DMAA

Capital Expenditures · Q1 FY2026 · quarter ended Mar 2026

Capital expenditures outflow shrinks to $0

Q1 FY2026 capital expenditures was $0, compared with $4 a year earlier. Trailing-twelve-month capital expenditures was -$4.

What to watch

Whether quarterly capital expenditures holds near $0 or moves back toward the trailing-twelve-month quarterly average of -$1.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearDec 2025
$0-100.0% YoY
LTMMar 2026
-$4-44466820965448.5% YoY
Capital Expenditures past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-100.0%——
1 year-100.0%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Capital Expenditures history

USD · from the cash flow

Latest · FY2025
0 USD
Year-over-year change
-100.0%

Capital Expenditures vs competitors

How DMAA compares with its peers on the latest reported figures

  • DMAA's LTM Mar 2026 capital expenditures of $4 is the largest of the 10 companies compared; the peer median is $0.
  • Its year-over-year change of -44466820965448.5% is the lowest of 2, against a peer median of +100.0%.
DMAA Competitors Peer median
Capital Expenditures for DMAA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
DMAADrugs Made In America Acquisition Corp. Ordinary SharesLTM Mar 2026$4 -44466820965448.5%——
TACHTitan Acquisition Corp.LTM Mar 2026$3 ———
RTACRenatus Tactical Acquisition Corp I Class A Ordinary SharesLTM Mar 2026$3 ———
TACOUBerto Acquisition Corp. UnitFY2025$0 ———
TACOBerto Acquisition Corp.FY2025$0 ———
ALFCenturion Acquisition Corp.LTM Mar 2026$0 ———
OYSEOyster Enterprises II Acquisition CorpFY2025$0 ———
SIMASIM Acquisition Corp. ILTM Mar 2026$0 ———
LOKVLive Oak Acquisition Corp. V Class A Ordinary SharesFY2025$0 ———
MLACMountain Lake Acquisition Corp.FY2025$0 +100.0%——
Peer median (excluding DMAA) $0+100.0%——

Competitors are the stored peer set for DMAA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Drugs Made In America Acquisition Corp. Ordinary Shares

NASDAQ:DMAA

Intrinsic Alpha fair value

Locked

Current Price

$10.90

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.